Glenn Tracey, CEO of Microsaic, commented, “Amedis is the perfect partner to distribute our compact, point of need MS technology, already having an impressive technology portfolio, unrivaled technical expertise, and full understanding of end user applications.
“Central Europe has shown impressive growth and opportunity for scientific instrumentation in recent years, and this agreement supports our growth strategy with select partners across the European region.”
Microsaic Systems plc (LON: MSYS), the developer of point of need mass spectrometry instruments, has today announced that it has signed a distribution agreement with Amedis, spol. s ro. Amedis will be the exclusive distributor of Microsaic-branded 4500 MiD® MS detectors in Slovakia.
Founded in 1991, Amedis distributes and provides application and service support for global brands across a wide range of technologies, including Liquid Chromatography Mass Spectrometry (“LCMS”), Inductively Coupled Plasma Mass Spectrometry (“ICPMS”), Gas Chromatography Mass Spectrometry (“GCMS”) and Nuclear Magnetic Resonance (“NMR”). Additionally, Amedis has expertise in medical technologies, such as Linear Accelerators, Medical Imaging and Dosimetry for Radiation Therapy.
Milos Sebedinsky, CEO of Amedis, added: “Amedis appreciates the possibility to widen its product portfolio with the top quality Microsaic product range, especially in the field of flash chromatography purification. Our plan also is to integrate 4500 MiD® with High Performance Liquid Chromatography systems we are selling, as a complement to other detectors.”
